Suppr超能文献

经皮冠状动脉支架植入术后再狭窄:细胞机制和内皮祖细胞的潜力(介入心脏病学家的简要指南)。

Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist).

机构信息

German Center for Cardiac and Vascular Research (DZHK) Standort Rhein-Main, Department of Cardiology, University Medical Center Mainz, 55131 Mainz, Germany.

出版信息

Cells. 2022 Jun 30;11(13):2094. doi: 10.3390/cells11132094.

Abstract

Coronary stents are among the most common therapies worldwide. Despite significant improvements in the biocompatibility of these devices throughout the last decades, they are prone, in as many as 10-20% of cases, to short- or long-term failure. In-stent restenosis is a multifactorial process with a complex and incompletely understood pathophysiology in which inflammatory reactions are of central importance. This review provides a short overview for the clinician on the cellular types responsible for restenosis with a focus on the role of endothelial progenitor cells. The mechanisms of restenosis are described, along with the cell-based attempts made to prevent it. While the focus of this review is principally clinical, experimental evidence provides some insight into the potential implications for prevention and therapy of coronary stent restenosis.

摘要

冠状动脉支架是全球最常见的治疗方法之一。尽管在过去几十年中,这些设备的生物相容性有了显著提高,但仍有多达 10-20%的病例存在短期或长期失败的风险。支架内再狭窄是一种多因素的过程,其病理生理学复杂且尚未完全被理解,其中炎症反应起着至关重要的作用。本篇综述为临床医生提供了一个关于导致再狭窄的细胞类型的简要概述,重点介绍了内皮祖细胞的作用。本文还描述了再狭窄的机制,以及为预防再狭窄而进行的基于细胞的尝试。虽然本篇综述的重点主要是临床方面的,但实验证据为预防和治疗冠状动脉支架内再狭窄提供了一些潜在的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8879/9265311/ce7b00656146/cells-11-02094-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验